Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Symbol
KZR
Shares outstanding
7,381,267 shares
Disclosed Ownership
664,314 shares
Ownership
9%
Form type
SCHEDULE 13D/A
Filing time
01 Apr 2026, 16:14:42 UTC
Date of event
30 Mar 2026

Sponsored

Quoteable Key Fact

"TANG CAPITAL MANAGEMENT LLC disclosed 9% ownership in Kezar Life Sciences, Inc. Common Stock, par value $0.001 per share (KZR) on 30 Mar 2026."

Quick Takeaways

  • TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13D/A for Kezar Life Sciences, Inc. Common Stock, par value $0.001 per share (KZR).
  • Disclosed ownership: 9%.
  • Date of event: 30 Mar 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 01 Apr 2026, 16:14.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 9% 664,314 0 664,314 /s/ Kevin Tang Manager 0001232621
KEVIN TANG 9% 664,314 0 664,314 /s/ Kevin Tang Self 0001178579
TANG CAPITAL PARTNERS, LP 0% 0 0 0 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner 0001191935
TANG CAPITAL PARTNERS INTERNATIONAL, LP 3.7% 272,272 0 272,272 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner 0002064011
TANG CAPITAL PARTNERS III, INC 5.3% 392,042 0 392,042 /s/ Kevin Tang Chief Executive Officer 0002036763
TANG CAPITAL PARTNERS IV, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer 0002036770
CONCENTRA BIOSCIENCES, LLC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer 0001970065